Related references
Note: Only part of the references are listed.Clinical Benefit of Cardiorenal Effects of Sodium-Glucose Cotransporter 2 Inhibitors JACC State-of-the-Art Review
Thomas A. Zelniker et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2020)
Left Ventricular Post-Infarct Remodeling Implications for Systolic Function Improvement and Outcomes in the Modern Era
Pieter van der Bijl et al.
JACC-HEART FAILURE (2020)
Omecamtiv Mecarbil in Chronic Heart Failure With Reduced Ejection Fraction Rationale and Design of GALACTIC-HF
John R. Teerlink et al.
JACC-HEART FAILURE (2020)
Empagliflozin Ameliorates Adverse Left Ventricular Remodeling in Nondiabetic Heart Failure by Enhancing Myocardial Energetics
Carlos G. Santos-Gallego et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Ticagrelor in patients with heart failure after acute coronary syndromes-Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial
Axel Akerblom et al.
AMERICAN HEART JOURNAL (2019)
Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care A First Analysis From the EMPRISE Study
Elisabetta Patorno et al.
CIRCULATION (2019)
Rivaroxaban With or Without Aspirin in Patients With Heart Failure and Chronic Coronary or Peripheral Artery Disease The COMPASS Trial
Kelley R. Branch et al.
CIRCULATION (2019)
Successful COMPASS, Disappointing COMMANDER HF, What Have We Learned From These Two Trials?
Yuhu He et al.
JOURNAL OF CARDIOVASCULAR PHARMACOLOGY (2019)
Hydralazine and nitrates in the treatment of heart failure with reduced ejection fraction
Abdallah Al-Mohammad
ESC HEART FAILURE (2019)
Evolocumab for Early Reduction of LDL Cholesterol Levels in Patients With Acute Coronary Syndromes (EVOPACS)
Konstantinos C. Koskinas et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
J. J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Ticagrelor or Prasugrel in Patients with Acute Coronary Syndromes
S. Schuepke et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Empagliflozin Reduced Mortality and Hospitalization for Heart Failure Across the Spectrum of Cardiovascular Risk in the EMPA- REG OUTCOME Trial
David Fitchett et al.
CIRCULATION (2019)
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC)
Borja Ibanez et al.
EUROPEAN HEART JOURNAL (2018)
2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS
Marco Valgimigli et al.
EUROPEAN HEART JOURNAL (2018)
Clinical Benefit of Evolocumab by Severity and Extent of Coronary Artery Disease: Analysis From FOURIER
Marc S. Sabatine et al.
CIRCULATION (2018)
Rivaroxaban with or without aspirin in patients with stable coronary artery disease: an international, randomised, double-blind, placebo-controlled trial
Stuart J. Connolly et al.
LANCET (2018)
Natural History of Patients Postacute Coronary Syndrome Based on Heart Failure Status
Andrew P. Ambrosy et al.
AMERICAN JOURNAL OF CARDIOLOGY (2018)
Contemporary management of patients referring to cardiologists one to three years from a myocardial infarction: The EYESHOT Post-MI study
Leonardo De Luca et al.
INTERNATIONAL JOURNAL OF CARDIOLOGY (2018)
Rivaroxaban in Patients with Heart Failure, Sinus Rhythm, and Coronary Disease
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Sacubitril/Valsartan Averts Adverse Post-Infarction Ventricular Remodeling and Preserves Systolic Function in Rabbits
Juan Torrado et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2018)
Alirocumab and Cardiovascular Outcomes after Acute Coronary Syndrome
G. G. Schwartz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
The Clinical Use of Ivabradine
Jacob S. Koruth et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2017)
Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease
Marc S. Sabatine et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Antiinflammatory Therapy with Canakinumab for Atherosclerotic Disease
P. M. Ridker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
2017 ACC/AHA/HFSA Focused Update of the 2013 ACCF/AHA Guideline for the Management of Heart Failure A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Failure Society of America
Clyde W. Yancy et al.
CIRCULATION (2017)
2015 ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation Task Force for the Management of Acute Coronary Syndromes in Patients Presenting without Persistent ST-Segment Elevation of the European Society of Cardiology (ESC)
Marco Roffi et al.
EUROPEAN HEART JOURNAL (2016)
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
Piotr Ponikowski et al.
EUROPEAN HEART JOURNAL (2016)
Early Aldosterone Blockade in Acute Myocardial Infarction The ALBATROSS Randomized Clinical Trial
Farzin Beygui et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
2015 ACC/AHA/SCAI Focused Update on Primary Percutaneous Coronary Intervention for Patients With ST-Elevation Myocardial Infarction An Update of the 2011 ACCF/AHA/SCAI Guideline for Percutaneous Coronary Intervention and the 2013 ACCF/AHA Guideline for the Management of ST-Elevation Myocardial Infarction
Glenn N. Levine et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2016)
Do statins reduce the risk of myocardial infarction in patients with heart failure? A pooled individual-level reanalysis of CORONA and GISSI-HF
Matthew J. Feinstein et al.
EUROPEAN JOURNAL OF HEART FAILURE (2015)
The Path to an Angiotensin Receptor Antagonist-Neprilysin Inhibitor in the Treatment of Heart Failure
Eugene Braunwald
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2015)
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes
Bernard Zinman et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction
Marc P. Bonaca et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Ezetimibe Added to Statin Therapy after Acute Coronary Syndromes
Christopher P. Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Differences in the Clinical Effects of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers: A Critical Review of the Evidence
Csaba Andras Dezsi
AMERICAN JOURNAL OF CARDIOVASCULAR DRUGS (2014)
Early eplerenone treatment in patients with acute ST-elevation myocardial infarction without heart failure: The Randomized Double-Blind Reminder Study
Gilles Montalescot et al.
EUROPEAN HEART JOURNAL (2014)
2014 AHA/ACC Guideline for the Management of Patients With Non-ST-Elevation Acute Coronary Syndromes A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
Ezra A. Amsterdam et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2014)
Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure
John J. V. McMurray et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Prasugrel versus Clopidogrel for Acute Coronary Syndromes
Donald R. Lynch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2013)
Lipid-altering efficacy of ezetimibe plus statin and statin monotherapy and identification of factors associated with treatment response: A pooled analysis of over 21,000 subjects from 27 clinical trials
Doralisa Morrone et al.
ATHEROSCLEROSIS (2012)
Efficacy of statin therapy in chronic systolic cardiac insufficiency: A meta-analysis
Shuning Zhang et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2011)
Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms.
Faiez Zannad et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Ivabradine and outcomes in chronic heart failure (SHIFT): a randomised placebo-controlled study
Karl Swedberg et al.
LANCET (2010)
Angiotensin-converting enzyme inhibition with perindopril in patients with prior myocardial infarction and/or revascularization: A subgroup analysis of the EUROPA trial
Michel E. Bertrand et al.
ARCHIVES OF CARDIOVASCULAR DISEASES (2009)
Acute Heart Failure Syndromes in Patients With Coronary Artery Disease Early Assessment and Treatment
James D. Flaherty et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2009)
Ticagrelor versus Clopidogrel in Patients with Acute Coronary Syndromes
Lars Wallentin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Ivabradine for patients with stable coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a randomised, double-blind, placebo-controlled trial
Kim Fox et al.
LANCET (2008)
Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
Luigi Tavazzi et al.
LANCET (2008)
Heart rate as a prognostic risk factor in patients with coronary artery disease and left-ventricular systolic dysfunction (BEAUTIFUL): a subgroup analysis of a randomised controlled trial
Kim Fox et al.
LANCET (2008)
Rosuvastatin in older patients with systolic heart failure
John Kjekshus et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Prasugrel versus clopidogrel in patients with acute coronary syndromes
Stephen D. Wiviott et al.
NEW ENGLAND JOURNAL OF MEDICINE (2007)
Management of post-myocardial infarction patients with left ventricular systolic dysfunction
Mihai Gheorghiade et al.
AMERICAN JOURNAL OF MEDICINE (2007)
Navigating the crossroads of coronary artery disease and heart failure
Mihai Gheorghiade et al.
CIRCULATION (2006)
Intensive statin therapy and the risk of hospitalization for heart failure after an acute coronary syndrome in the PROVE IT-TIMI 22 study
BM Scirica et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2006)
Reassessment of dobutamine, dopamine, and milrinone in the management of acute heart failure syndromes
M Bayram et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure
B Pitt et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Sudden death in patients with myocardial infarction and left ventricular dysfunction, heart failure, or both
SD Solomon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Antiarrhythmic effect of carvedilol after acute myocardial infarction - Results of the Carvedilol Post-Infarct Survival Control in Left Ventricular Dysfunction (CAPRICORN) trial
J McMurray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Intensive versus moderate lipid lowering with statins after acute coronary syndromes
CP Cannon et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
Determinants and prognostic impact of heart failure complicating acute coronary syndromes observations from The Global Registry of Acute Coronary Events (GRACE)
PG Steg et al.
CIRCULATION (2004)
Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes - Phase Z of the A to Z trial
JA de Lemos et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
An international perspective on heart failure and left ventricular systolic dysfunction complicating myocardial infarction: the VALIANT registry
EJ Velazquez et al.
EUROPEAN HEART JOURNAL (2004)
Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both
MA Pfeffer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Recent clinical trials with omapatrilat: New developments
A Zanchi et al.
CURRENT HYPERTENSION REPORTS (2003)
Eplerenone, a selective aldosterone blocker, in patients with left ventricular dysfunction after myocardial infarction
B Pitt et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Frequency, patient characteristics, and, outcomes of mild-to-moderate heart failure complicating ST-segment elevation acute myocardial infarction: Lessons from 4 international fibrinolytic therapy trials
D Hasdai et al.
AMERICAN HEART JOURNAL (2003)
Double-blind comparison between zofenopril and lisinopril in patients with acute myocardial infarction: Results of the Survival of Myocardial Infarction Long-term Evaluation-2 (SMILE-2) study
C Borghi et al.
AMERICAN HEART JOURNAL (2003)
Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAL randomised trial
K Dickstein et al.
LANCET (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
Effect of carvedilol on outcome after myocardial infarction in patients with left-ventricular dysfunction: the CAPRICORN randomised trial
HJ Dargie et al.
LANCET (2001)
Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
GG Schwartz et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Cardiac remodeling-concepts and clinical implications: A consensus paper from an international forum on cardiac remodeling
JN Cohn et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2000)
Share Paper
